000 06065cam a2200637Ii 4500
001 ocn936379312
003 OCoLC
005 20190328114814.0
006 m o d
007 cr cnu|||unuuu
008 160202t20162016enka ob 001 0 eng d
040 _aN$T
_beng
_erda
_epn
_cN$T
_dYDXCP
_dIDEBK
_dEBLCP
_dN$T
_dOPELS
_dCDX
_dOCLCF
_dKNOVL
_dCOO
_dOCLCQ
_dU3W
_dMERUC
_dD6H
_dCEF
_dRRP
_dOCLCQ
_dAU@
_dUKMGB
_dOCLCQ
015 _aGBB6I9531
_2bnb
016 7 _a017993084
_2Uk
019 _a945766669
020 _a9780128021651
_q(electronic bk.)
020 _a0128021659
_q(electronic bk.)
020 _a0128021470
020 _a9780128021477
020 _z9780128021477
035 _a(OCoLC)936379312
_z(OCoLC)945766669
043 _an-us---
050 4 _aQP144.F85
072 7 _aHEA
_x010000
_2bisacsh
072 7 _aHEA
_x012000
_2bisacsh
072 7 _aHEA
_x020000
_2bisacsh
072 7 _aMED
_x076000
_2bisacsh
082 0 4 _a613.2
_223
245 0 0 _aNutraceuticals : efficacy, safety and toxicity /
_h[electronic resource]
_cedited by Ramesh C. Gupta.
264 1 _aLondon :
_bAcademic Press,
_c2016.
264 4 _c�2016
300 _a1 online resource :
_billustrations
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
588 0 _aOnline resource; title from PDF title page (Ebsco, viewed February 17, 2016).
504 _aIncludes bibliographical references and index.
520 _aNutraceuticals: Efficacy, Safety and Toxicity brings together all current knowledge regarding nutraceuticals and their potential toxic effects as written by the scientists at the forefront of their study. Users will find an introduction to nutraceuticals, herbal medicines, ayurvedic medicines, prebiotics, probiotics, and adaptogens, along with their use and specific applications. This essential reference then discusses the mechanism of action for the judicious use of these nutraceuticals and the best tools for their evaluation before detailing the safety and toxicity of nutraceuticals and their interactions with other therapeutic drugs. Finally, and crucially, regulatory aspects from around the world are covered, providing a comprehensive overview of the most effective tools for the evaluation, safety, and toxicity of nutraceuticals, prebiotics, probiotics, and alternative medicines.
505 0 _aFront Cover; Nutraceuticals; Copyright Page; Dedication; Contents; List of Contributors; Introduction; Introduction; References; I. Applications of Nutraceuticals in Common Diseases and Disorders; 1 Nutraceuticals in CNS Diseases: Potential Mechanisms of Neuroprotection; Introduction; Polyphenols; Counteracting Oxidative Stress as a Mechanism of Neuroprotection; Direct Antioxidant Action of Quercetin; Potential Role of Hormesis in Neuroprotection; Modulation of the Nrf2-ARE Pathway as a Mechanism of Quercetin Neuroprotection.
505 8 _aModulation of Paraoxonase 2 (PON2) as a Potential Novel Mechanism of Quercetin NeuroprotectionParaoxonase 2; Paraoxonase 2 in the Central Nervous System; Gender Differences in Paraoxonase 2 Expression; Modulation of Paraoxonase 2; Modulation of Paraoxonase 2 by Quercetin; The Issue of Metabolites; Concluding Remarks and Future Directions; Acknowledgments; References; 2 Prevention of Neurodegenerative Disorders by Nutraceuticals; Introduction; Nutraceuticals for the Prevention and Amelioration of AD; Nutraceuticals for the Prevention and Amelioration of PD.
505 8 _aNutraceuticals for the Prevention and Amelioration of ASDConcluding Remarks and Future Directions; References; 3 Cognitive Effects of Nutraceuticals; Introduction; Biological Basis of Cognition; Overview of Cognition; Cellular Basis of Information Storage; Synaptic Plasticity as a Physical Basis for Memory; Biological Basis of Dementia; Nutraceuticals with Potential Cognitive Enhancing Functions; Ginkgo biloba; Positive Effects; Potential Mechanisms; Negative or Null Effects; Bacopa monnieri; Positive Effects; Potential Mechanisms; Negative or Null Effects; Ginseng; Positive Effects.
505 8 _aPotential MechanismNegative or Null Effects; Phosphatidylserine; Positive Effects; Potential Mechanisms; Negative or Null Effects; Caffeine; Positive Effects; Potential Mechanisms; Negative or Null Effects; Centella asiatica, Ephedra sinica, and Crocus sativus; Potential Concerns of Cognitive Enhancement; Concluding Remarks and Future Directions; References; 4 Nutraceuticals in Cardiovascular Diseases; Introduction; Cardiac Dysfunction; Features of Cardiac Disease; Hypertension; Coronary Artery Disease (CAD)-Atherosclerosis; Ischemia; Hypertrophy; Oxidative Stress; Vascular Injury.
505 8 _aBiomarkers of Heart DiseaseTherapeutic Response to Heart Disease; Phytotherapeutic Strategies; Nutraceuticals; Cruciferous Vegetables; Bulbous Plants; Tea; CoQ10; Turmeric; Grape Skin; Fish Oil/Olive Oil; Vegetables; Carnitine; Soy; Concluding Remarks and Future Directions; References; 5 Antiatherosclerotic Efficacy of Nutraceuticals; Introduction; Pathogenesis of Atherosclerosis and Possible Points of Therapeutic Intervention; Role of LDL; Atherosclerotic Plaque Formation; Existing and Emerging Antiatherosclerotic Therapies; Nutraceuticals with Antiatherosclerotic Activity.
650 0 _aFunctional foods.
650 0 _aNutrition.
650 7 _aHEALTH & FITNESS
_xHealthy Living.
_2bisacsh
650 7 _aHEALTH & FITNESS
_xHolism.
_2bisacsh
650 7 _aHEALTH & FITNESS
_xReference.
_2bisacsh
650 7 _aMEDICAL
_xPreventive Medicine.
_2bisacsh
650 7 _aFunctional foods.
_2fast
_0(OCoLC)fst00936070
650 7 _aNutrition.
_2fast
_0(OCoLC)fst01042187
655 4 _aElectronic books.
700 1 _aGupta, Ramesh C.
_q(Ramesh Chandra),
_d1949-
_eauthor,
_eeditor.
776 0 8 _iPrint version:
_tNutraceuticals : efficacy, safety and toxicity.
_dAmsterdam, [Netherlands] : Academic Press, �2016
_hxiv, 1021 pages
_z9780128021477
856 4 0 _3ScienceDirect
_uhttp://www.sciencedirect.com/science/book/9780128021477
999 _c247281
_d247281